Life-Cycle Management

Regulatory strategy and assistance through product life-cycle post-approval to ensure compliance, safety and optimal product maintenance

Life-Cycle Management

Once a medicinal product receives the Marketing Authorization approval and the product is ready to be commercialized, further regulatory requirements need to be taken into account throughout the product life-cycle to ensure a compliant, sustained, and successful product use.

Up to 70% of the post-approval activities of a medicinal product, including pharmacovigilance, could involve maintenance. Thus, product maintenance is a field with a large potential for improvement in both management and execution.

Asphalion has many years of experience in product Life-Cycle Management and is responsible for the portfolio maintenance of large, medium-sized and small pharmaceutical and biotech companies.

As a team of specialists in current medicinal regulations in EU, USA and many other countries, Asphalion can assist you in all medicinal product life-cycle management needs.

Life-Cycle Management Solutions

Regulatory strategy and maintenance support throughout product life-cycle post-approval:

  • Complete portfolio maintenance for EU and US: management of variations, amendments, renewals, supplements, modifications, requests for information, and notifications, among others
  • Dossier updates (CTD updates) and maintenance. Strategic writing and review for the preparation of complete dossier updates for new registration procedures, including expert’s signature. Update of dossier modules to respond to further generated clinical evidence
  • CMC maintenance activities (aligned with compliance requirements) and Expert Reports
  • Annual Safety Reports and other regulatory requirements
  • Full cycle submission management and support


Expert support on responses to Deficiency Letters.


Dossier consolidation of legacy dossiers (Mod. 2.3 and 3) for eCTD publishing.


Ad hoc regulatory strategy.


Pharmacovigilance strategy and operations that responds to legal requirements and best enhances the safety profile of your product in real world application:

  • QPPV (Qualified Person Responsible for Pharmacovigilance) appointment and follow-up, nationally and in EU and US
  • Writing of Periodic Safety Reports (PSUR)
  • Literature monitoring
  • Pharmacoepidemiology
  • ICSR (Individual Safety Case Report) management, including collection, evaluation, processing, distribution and reporting of cases.
  • Preparation of PSMF (Pharmacovigilance System Master File), RMP (Risk Management Plans), PSURs (periodic Safety Update Reports), and handling of Case Management.
  • Implementation of Adverse Event reporting tool.
  • Social media deep screening to monitor drug safety information within digital environment:
    • Active listening of brand/product
    • Multiple digital platforms with more than 2 billion URLs
    • 24/7/365 monitoring solution
    • Segment by language and/or country
  • Analysis and validation of contents:
    • Expert drug safety team
    • In accordance with legislation and/or client requirements
    • Immediate communication of detected adverse drug reactions


Management and follow-up of data and evidence generation post-approval.

  • Data generation and consolidation for evidence demonstration: data collection or extraction, verification, mapping and cleaning
  • Safety data exchange agreements
  • Data entry and submission for xEVMPD, IDMP, SPL and other formats, as needed
  • Publishing and submission for human medicines in eCTD format for EU and US
    • Comprehensive eCTD services
    • eCTD compilation and publishing
    • Full life-cycle support for Europe, USA, Canada, Switzerland, Saudi Arabia, GCC, and more
    • Information management (RIMS solution)
    • Software installation, training, validation and support
  • Adequation and data retrieval and management to ISO IDMP standards
  • Tool review and selection (RFP, RFI)
  • Tool and process adaptation and implementation
  • Data mapping with SPOR master data
  • Gap analysis of IDMP readiness


Ensuring complete and constant subjection to compliance based on specific regional regulations:

  • Inspection and Audit system and compliance.
  • Audit PV systems and support for Quality System set-up
  • CMC compliance and regulatory gap analysis
  • Review of promotional or training materials and of commercial activities post-authorization.
  • Management of labelling.


Readability tests for further EU registration processes.


Data retrieval for price and reimbursement strategies.


Price and reimbursement for new medicinal products and for generic products in Spain.


Marketing Authorization transfer management.


Support in UK with new MHRA requirements:

  • Acting as UK-QPPV
  • Reporting adverse events and submissions of PSURs to MHRA
  • Batch update all your records with the new QPPV and PSMF information in the Article 57 database
  • Holding your Pharmacovigilance system master file at our location
  • Submission in UK using the new National Portal
  • National procedures in UK, accelerated and Rolling reviews, national variations
  • Amended packaging and leaflet
  • Baselines for grandfathered centralized products
  • Assessment of Brexit Regulatory impact and development of Brexit transition strategy
  • Management of MAH transfers and other necessary variations


Medical device related post-commercialization regulation:

  • Medical device post-market surveillance Plans and Reports
  • Technical File core-parts revision/compilation/maintenance for medical devices
  • Quality management System (QMS) design and implementation, based on ISO 13485 and 21CFR 820 Quality Management Systems
  • Manufacturer and supplies audits
  • QMS self-inspections
  • Notified Body /FDA – mock inspections


Validation and qualification of medical devices manufacturing process, equipment and facilities.


SaMD validation for medical devices: Standalone software as medical device (SaMD). Computerized Systems as part of a medical device.

Schedule a free meeting!

Discuss your case with our experts and receive a valuable feedback


Why Asphalion?

At Asphalion, we have many years of experience in product Life-Cycle Management and are responsible for product maintenance of large, medium-sized and small pharmaceutical and biotech companies. We provide this maintenance activities for multiple regional contexts, such as Spain, the EU and US in terms of maintaining and updating technical dossiers and CMC information, as well as reviewing promotional materials for compliant marketing.

Our company stays up-to-date in regards of the pharmacovigilance requirements and regulations. Also, considering the amount of information disseminated on social networks, we can help you monitor drug safety information that appears on social media sites with a new automatic Active Listening System.

Related Resources

Marketing Authorization Expansion in Europe

Marketing Authorization Expansion in Europe

A case study about Marketing Authorization Expansion in Europe. A small European
Pharmaceutical company with
local activity in its country, with a
growth strategy aiming to
expand to international
markets but lacking experience
and capability in managing
complex EU procedures.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Related News & Events

EVENT | Symposium AEFI 2024

¡Mañana arranca el 42º Symposium de AEFI! No olvidéis visitarnos en la mesa 6 para conocer de todos los servicios que ofrecemos. Os recordamos los talleres que impartirán nuestros expertos

EVENT | RAPS Euroconvergence

Dates: May 6-8 | Berlin Congress Centre Day 1 at RAPS! ASPHALION’s team is in Berlin!! Come by booth B2 to get to know us and see the array of

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting